Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab
Clinical trial NCT00866320 · COMPLETED
Trial details
- NCT number
- NCT00866320
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-12-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.